![](/wp-content/uploads/2022/04/April-13.-2022-Cover.png)
$599
Viatris Glargine Recalled; Carbon Health Launches Diabetes Management Program
Two cardiometabolic-related news items have been observed: Viatris announced a voluntary recall of one batch of its unbranded insulin glargine U100 10 mL vials due to a potential missing label; and Carbon Health announced the launch of its personalized diabetes management program. Below, FENIX provides highlights and insights for the respective new items.